Real-world effectiveness of hemodialysis modalities: a retrospective cohort study
Abstract Background Results from the CONVINCE clinical trial suggest a 23% mortality risk reduction among patients receiving high-volume (> 23 L) hemodiafiltration. We assessed the real-world effectiveness of blood-based kidney replacement therapy (KRT) with hemodiafiltration vs. hemodialysis in...
Saved in:
Main Authors: | Yan Zhang, Anke Winter, Belén Alejos Ferreras, Paola Carioni, Otto Arkossy, Michael Anger, Robert Kossmann, Len A. Usvyat, Stefano Stuard, Franklin W. Maddux |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-01-01
|
Series: | BMC Nephrology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12882-024-03934-y |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Blood pressure control with active ultrafiltration measures and without antihypertensives is essential for survival in hemodiafiltration and hemodialysis programs for patients with CKD: a prospective observational study
by: Franklin Geovany Mora-Bravo, et al.
Published: (2025-01-01) -
Hemodiafiltration with endogenous reinfusion for uremic toxin removal in patients undergoing maintenance hemodialysis: a pilot study
by: Renhua Lu, et al.
Published: (2024-12-01) -
Systemic Lupus Erythematosus in Hemodialysis: Survival Comparison and Mortality-Related Factors
by: Hwajeong Lee, et al.
Published: (2025-01-01) -
Risk factors for the mortality of hemodialysis patients with COVID-19 in northern Hunan province, China
by: Zhangxiu He, et al.
Published: (2025-01-01) -
Effects of low-flux and high-flux hemodialysis on the survival of elderly maintenance hemodialysis patients
by: Wanqing Huang, et al.
Published: (2024-12-01)